NewsStocksSun Pharma Share Price Ends Nov 13 Session at Rs 1,876 After Surpassing Key Resistance Level

Sun Pharma Share Price Ends Nov 13 Session at Rs 1,876 After Surpassing Key Resistance Level

Author: Economic Times Markets·

Key Takeaways

  • •Sun Pharmaceutical Industries Ltd ended the November 13, 2026 trading session at Rs 1,876.0, according to The Economic Times' live stock coverage.
  • •The stock surpassed a key resistance level during the session, a technical milestone traders generally watch for confirmation in subsequent sessions.
  • •The live blog included bonus and dividend sections but contained no specific terms for any corporate action, which under India's listing framework would be disclosed through exchange filings.
  • •Sun Pharma is India's largest pharmaceutical company by market capitalisation, with shares listed on both the NSE and BSE and inclusion in the Nifty 50 index.
  • •The company's product portfolio covers generics, specialty medicines, and active pharmaceutical ingredients sold in markets worldwide.
Sun Pharma Share Price Ends Nov 13 Session at Rs 1,876 After Surpassing Key Resistance Level

Shares of Sun Pharmaceutical Industries Ltd ended the trading session of November 13, 2026, at Rs 1,876.0, according to The Economic Times' live blog tracking the stock through the day.

The live coverage noted that the stock surpassed a key resistance level during the session. A resistance level is a technical price point beyond which a stock has historically struggled to advance, and moves above such thresholds are a standard element of technical analysis monitored by market participants. In standard technical analysis practice, traders commonly watch whether a stock holds above a broken resistance level in subsequent sessions before treating the breakout as confirmed. The blog also referenced Sun Pharma's beta, the standard measure of a stock's volatility relative to the broader market, as reflecting the company's market positioning.

In addition, the live blog carried dedicated sections covering the company's bonus updates, dividend updates, stock details, price movement, and stock movement analysis, alongside broader Sun Pharma news and current trading insights. No specific terms for a bonus or dividend action were included in the live coverage; under India's listing framework, listed companies disclose such corporate actions through filings with the stock exchanges.

About Sun Pharmaceutical Industries

Sun Pharma, headquartered in Mumbai, is India's largest pharmaceutical company by market capitalisation. Its equity shares are listed on both the National Stock Exchange of India (NSE) and BSE, and the stock is a constituent of the Nifty 50, the benchmark index tracking India's largest listed companies, meaning its price movements feed into the index's overall performance. The company's portfolio spans generics, specialty medicines, and active pharmaceutical ingredients, sold across markets worldwide.

The full live blog, including the intraday price tracker and company statistics, is available on The Economic Times Markets website: Sun Pharma Share Price Live Updates. Historical price data for the stock is available on The Economic Times' Sun Pharmaceutical Industries price page.